The biopharmaceutical industry is approaching a defining moment. Scientific breakthroughs across cell and gene therapies, precision oncology and novel...
In an industry defined by scientific complexity, global regulatory shifts and rising expectations for speed and quality, pharma and biotech organizati...
Patient registries have become one of the most powerful tools Foundations can use to advance research, improve care and amplify the patient voice. The...
From Regulatory Necessity to Strategic Advantage AI in Labeling is emerging as an important milestone. After all, labeling has long been one of the mo...
In life sciences outsourcing, few terms are used as interchangeably, and as confusingly, as Contract Research Organisation and Clinical Research Organ...
How AI in Clinical Trials, Decentralized Clinical Trials and Real-World Evidence (RWE) Are Redefining Research Clinical research is entering 2026 with...
A Year of Impact 2025 was a year of progress and partnership, where sponsors looked for the best CRO partner for global clinical trials, demanded insp...
The Navitas Advantage: Powering the Future of Pharma & Biotech In today’s fast-moving world of pharma and biotech, innovation isn’t ...
In a world where scientific innovation is accelerating fast, regulatory strategy is a competitive advantage. Pharma & biotech companies need clari...
Are you ready to lead the next wave of transformation in life sciences? Across Navitas’ industry-leading networks, pvnet®, pvconnect®...
New “Ask Your Biostatistician” Video Clinical trials generate data from dozens of sources, EDC systems, laboratories, imaging vendors, s...
Pharma’s digital maturity has accelerated recently, and emerging technologies are core enablers of faster R&D. As we move into 2026, five d...
PV India 2025 once again proved why it remains one of the most sought-after pharmacovigilance peer networks, bringing together senior drug safety lead...
On this World Diabetes Day, we reaffirm our global commitment to reducing the burden of diabetes. Because it embodies the science behind better diabet...
Accelerating First-to-Market Success in Generics Bioavailability and Bioequivalence (BABE) studies are critical gateways to bringing safe, effective, ...
The complexities and challenges of data is increasing at an unprecedented rate and excellence in Clinical Data Management (CDM) has become a defining ...
The second Navitas Life Sciences Ad Promo Roundtable, held on September 25, 2025, convened more than forty experts from across global pharma to examin...
Be First-to-Market with Our Bioavailability & Bioequivalence (BABE) CRO Services Bioavailability (BA) and Bioequivalence (BE) studies are critical...
Navitas Life Sciences’ medical information contact center (MICC) services help global clients achieve operational excellence, ensure compliance...
Insights from the PHUSE Chennai SDE Navitas Life Sciences was proud to be part of the highly attended PHUSE India SDE in Chennai, sharing our expertis...